As of 2025-12-24, the EV/EBITDA ratio of Crescita Therapeutics Inc (CTX.TO) is 0.47. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTX.TO's latest enterprise value is 0.83 mil CAD. CTX.TO's TTM EBITDA according to its financial statements is 1.76 mil CAD. Dividing these 2 quantities gives us the above CTX.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 0.8x - 3.2x | 0.9x |
| Forward P/E multiples | 2.1x - 5.6x | 2.5x |
| Fair Price | 0.50 - 0.95 | 0.58 |
| Upside | 7.1% - 104.5% | 24.9% |
| Date | EV/EBITDA |
| 2025-12-22 | 0.47 |
| 2025-12-19 | 0.31 |
| 2025-12-18 | 0.31 |
| 2025-12-17 | -0.00 |
| 2025-12-15 | 0.31 |
| 2025-12-12 | 0.31 |
| 2025-12-09 | 0.26 |
| 2025-12-08 | 0.31 |
| 2025-12-05 | 0.31 |
| 2025-12-04 | 0.21 |
| 2025-12-01 | -0.00 |
| 2025-11-28 | 0.21 |
| 2025-11-26 | 0.10 |
| 2025-11-25 | -0.06 |
| 2025-11-20 | 0.42 |
| 2025-11-19 | 0.53 |
| 2025-11-18 | 0.53 |
| 2025-11-17 | 0.37 |
| 2025-11-14 | 0.42 |
| 2025-11-13 | 0.53 |
| 2025-11-12 | 0.74 |
| 2025-11-11 | 0.58 |
| 2025-11-10 | 0.58 |
| 2025-11-07 | 0.63 |
| 2025-11-06 | 0.63 |
| 2025-11-05 | 0.74 |
| 2025-11-03 | 0.37 |
| 2025-10-29 | 0.37 |
| 2025-10-28 | 0.53 |
| 2025-10-24 | 0.53 |
| 2025-10-23 | 0.37 |
| 2025-10-22 | 0.42 |
| 2025-10-21 | 0.42 |
| 2025-10-20 | 0.53 |
| 2025-10-17 | 0.37 |
| 2025-10-16 | 0.37 |
| 2025-10-15 | 0.42 |
| 2025-10-07 | 0.47 |
| 2025-10-03 | 0.37 |
| 2025-10-02 | 0.31 |
| 2025-10-01 | 0.74 |
| 2025-09-26 | 0.58 |